We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Singapore Updates Guidance on Reporting Adverse Events in Drug Trials
Singapore Updates Guidance on Reporting Adverse Events in Drug Trials
November 19, 2007
Singapore’s Health Sciences Authority (HSA) has revised its guidelines for reporting safety information related to all phases of clinical drug trials conducted in that country.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor